Cytomegalovirus (CMV) Infection Market

As per the Delveinsight, the total number of diagnosed cytomegalovirus patients in the 7MM were found to be 110,580 in 2017.

The cytomegalovirus infection market in the 7MM was estimated to be approx. USD 1195.27 million in 2017. The United States was observed to hold the highest market share of the Cytomegalovirus infection market among 7MM.

The key companies in the Cytomegalovirus (CMV) Infection Market includes BioTest, Merck Sharp & Dohme Corp, Shire, Atara Biotherapeutics, ViraCyte and many others.

For more detailed information on Cytomegalovirus (CMV) Infection Market, visit: https://www.delveinsight.com/blog/cytomegalovirus-seroprevalence-market/